E525-0296 Screening compound: 2-(2-furylmethyl)-3-methyl-N~3~-(2-methylcyclohexyl)-1-oxo-1,2,3,4-tetrahydropyrazino[1,2-a][1,3]benzimidazole-3-carboxamide

E525-0296 Screening compound: 2-(2-furylmethyl)-3-methyl-N~3~-(2-methylcyclohexyl)-1-oxo-1,2,3,4-tetrahydropyrazino[1,2-a][1,3]benzimidazole-3-carboxamide
E525-0296 Screening compound: 2-(2-furylmethyl)-3-methyl-N~3~-(2-methylcyclohexyl)-1-oxo-1,2,3,4-tetrahydropyrazino[1,2-a][1,3]benzimidazole-3-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound E525-0296
2-(2-furylmethyl)-3-methyl-N~3~-(2-methylcyclohexyl)-1-oxo-1,2,3,4-tetrahydropyrazino[1,2-a][1,3]benzimidazole-3-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

E525-0296

Molecular Formula

C24H28N4O3 (C24 H28 N4 O3)

Compound Name

2-(2-furylmethyl)-3-methyl-N~3~-(2-methylcyclohexyl)-1-oxo-1,2,3,4-tetrahydropyrazino[1,2-a][1,3]benzimidazole-3-carboxamide

IUPAC name

11-[(furan-2-yl)methyl]-12-methyl-N-(2-methylcyclohexyl)-10-oxo-1811-triazatricyclo[7.4.0.0^{27}]trideca-2468-tetraene-12-carboxamide

SMILES

CC(CCCC1)C1NC(C(C)(Cn1c2nc3c1cccc3)N(Cc1ccco1)C2=O)=O

InChI

InChI=1S/C24H28N4O3/c1-16-8-3-4-10-18(16)26-23(30)24(2)15-27-20-12-6-5-11-19(20)25-21(27)22(29)28(24)14-17-9-7-13-31-17/h5-7,9,11-13,16,18H,3-4,8,10,14-15H2,1-2H3,(H,26,30)

InChI Key

CFJSPDRPCWQWBS-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14895217

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

420.51

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

4.324

Distribution Coefficient, logD

4.324

Water Solubility, LogSw

-4.19

Polar Surface Area

58.441

Acid Dissociation Constant (pKa)

15.04

Base Dissociation Constant (pKb)

1.51

Number of Chiral Centers

3.00

Percent sp3 carbon bonding

45.80

E525-0296 in Drug Discovery

Included in Screening Libraries

Anti-infective Library (19449 compounds)

Antimitotic Tubulin Library (17355 compounds)

Cyclic Ugi PPI Library (9586 compounds)

DGK Inhibitors Library (10558 compounds)

Protein-Protein Interaction Library (218420 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Infections
  • Immune system
  • animal
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Cancer
  • Digestive system
  • Hemic and lymphatic
  • Skin
  • Metabolic
  • Immune system
Mechanism of action:
  • PPI modulators
  • PPI modulators
Structure:
  • Cyclic compounds
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with E525-0296 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound E525-0296?
Check Price and Availability of E525-0296, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of E525-0296 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for E525-0296
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for E525-0296
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of E525-0296 available by request